Davia Viellechner

Davia Viellechner currently serves as the Director of Marketing for Cell Therapy at Kite Pharma, a position held since September 2022. Prior to this, Davia held the role of Senior Industry Expert at Triton Investment Management from December 2021 to August 2022. Between 2016 and November 2021, positions included President and Director of Portfolio Management at PARI GmbH. Additional experience includes a Principal role at The Boston Consulting Group from 2007 to 2016, a brief internship at Roche in 2002, and work as a Laboratory Assistant at CellControl from 1999 to 2001. Davia Viellechner earned an MBA from INSEAD in 2010, a Ph.D. in Oncology from the University of Cambridge in 2006, and a B.S. in Molecular Biotechnology from the Technical University of Munich in 2003.